Latest Boardroom Shifts News

Amotiv Limited reported steady FY25 financials with marginal revenue growth and a slight EBITA dip, while unveiling its ambitious Amotiv2030 strategy to drive future shareholder value amid ongoing market challenges.

Canyon Resources confirms the Minim Martap Bauxite Project as a world-class asset with robust economics and begins construction ahead of first shipment in mid-2026.

Johns Lyng Group has officially been acquired by Sherwood BidCo, controlled by Pacific Equity Partners, with shareholders receiving $4.00 per share or equity in the new entity. The company will be delisted from the ASX on October 24, marking a new chapter under private ownership.

Spectur Limited has successfully raised $2.3 million through a premium-priced placement to fast-track its AI Cloud Platform and sovereign cloud capabilities, alongside notable board changes ahead of its AGM.

Highfield Resources has secured a A$10 million convertible note investment from existing strategic shareholders following the collapse of a proposed strategic transaction with China Minmetals and Yankuang Energy. The company also received renewed institutional backing from the Government of Navarra for its flagship Muga Potash Project.

Janison Education Group reported solid FY25 results with 9% revenue growth and the commercial launch of its AI platform Jai, positioning itself strongly in the expanding global digital assessment market.

Anatara Lifesciences reports steady progress in its anti-obesity pre-clinical studies with results expected by year-end, while preparing its GaRP gastrointestinal health data for publication amid ongoing commercial talks. The company also announces a key board appointment and a $1.2 million capital raise.

Insurance Australia Group (IAG) reported strong FY25 results and upgraded its FY26 guidance, reflecting the completed RACQ acquisition and ongoing strategic growth initiatives.

Brambles Limited reported robust FY25 financial results and sustainability achievements, highlighting a $1 billion free cash flow milestone and ambitious 2030 regenerative targets at its 2025 AGM.

Firebrick Pharma reports a $1.94 million cash reserve after a $1.4 million placement, supporting expanded Nasodine sales across Southeast Asia and the US. Board changes and increased operational costs mark a pivotal quarter for the pharmaceutical innovator.

Cochlear Limited reports steady FY25 financials alongside the launch of its innovative Nucleus Nexa cochlear implant system, setting the stage for projected double-digit profit growth in FY26.

Bellevue Gold Limited reported a robust September quarter with production and sales exceeding expectations, alongside a pioneering net zero emissions milestone. The company is well positioned for growth in FY26 with strategic leadership appointments and improved operational efficiencies.